文献速递中医骨伤中药与中成药合理使用

骨碎补拮抗糖皮质激素所致斑马鱼幼虫矿化减少:调控成骨与破骨细胞活性

Gu Sui Bu (Drynaria fortunei J. Sm.) antagonizes glucocorticoid-induced mineralization reduction in zebrafish larvae by modulating the activity of osteoblasts and osteoclasts.
PubMed 文献 · J Ethnopharmacol · 2022-07-19

本研究以斑马鱼幼虫建立糖皮质激素性骨质疏松(GIOP)模型,评估骨碎补(GSB)的疗效与机制。GSB 显著逆转地塞米松所致钙化延迟,通过增加胶原I、骨桥蛋白和骨连接蛋白表达增强成骨细胞活性,并通过降低mmp9和mmp13a表达抑制骨吸收。柚皮苷被鉴定为GSB抗GIOP的活性成分之一;GSB治疗后骨吸收活性保留,有利于维持正常骨重建。

要点

  • GSB可逆转地塞米松诱导的斑马鱼幼虫钙化延迟。
  • GSB增强成骨细胞活性并降低mmp9、mmp13a表达抑制骨吸收。
  • 柚皮苷为GSB抗GIOP活性的成分之一。

核心结论

  • 骨碎补具有成骨作用,可能是治疗GIOP有效且经济的选择。
  • GSB治疗后骨吸收活性保留,有利于维持正常骨重建。
  • 柚皮苷是GSB抗GIOP活性的成分之一。

研究设计与样本

  • 研究通过优化斑马鱼幼虫饲养条件以及地塞米松剂量与持续时间,建立体内GIOP模型。
  • 采用钙化素染色评估骨钙化,并基于椎骨钙化率建立评分系统以量化矿化程度。
  • 采用实时定量PCR检测骨细胞分化与功能相关基因表达,采用高效液相色谱鉴定GSB提取物中的柚皮苷。

主要发现

  • GSB显著逆转地塞米松诱导的斑马鱼幼虫钙化延迟。
  • GSB通过增加胶原I、骨桥蛋白和骨连接蛋白表达增强成骨细胞活性。
  • GSB通过降低mmp9和mmp13a表达抑制骨吸收。
  • GSB治疗后骨吸收活性保留。

临床怎么用

  • GSB可能作为GIOP的有效且经济治疗选择,但需进一步临床验证。
  • GSB的成骨作用及保留骨吸收活性的特点可能有利于维持正常骨重建。

局限性

  • 研究仅基于斑马鱼幼虫模型,结论外推至人类需谨慎。
  • 未报告GSB在哺乳动物或临床研究中的疗效与安全性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Gu Sui Bu (GSB), the dried rhizome of Drynaria fortunei J. Sm., is widely used in traditional Chinese medicine for treating fractures and osteoporosis. Although glucocorticoids are widely prescribed in modern medicine, the efficacy of GSB in treating glucocorticoid-induced osteoporosis (GIOP) remains unclear. AIM OF THE STUDY: GIOP is one of the most prevalent forms of osteoporosis and increases the risk of fracture, which can cause severe complications in elderly people. Safe, efficacious, and cost-effective treatment options for GIOP are thus warranted. The present study investigated the efficacy and mechanism of GSB for treating GIOP. MATERIALS AND METHODS: We established an efficient and robust in vivo GIOP model by optimizing zebrafish larvae rearing conditions and the dose and duration of dexamethasone treatment. Bone calcification was evaluated through calcein staining. To quantify the degree of vertebral mineralization in the larvae, we developed a scoring system based on the rate of vertebral calcification; this system reduced quantification errors among individual zebrafish caused by inconsistencies in staining or imaging parameters. Quantitative real-time polymerase chain reaction was used to access the expression levels of genes essential to the differentiation and function of bone cells. High-performance liquid chromatography was employed to identify naringin in the GSB extract. RESULTS: GSB significantly reversed the dexamethasone-induced calcification delay in zebrafish larvae. GSB enhanced osteoblast activity by increasing the expression of collagen I, osteopontin, and osteonectin and repressed bone resorption by decreasing the expression of matrix metalloproteinases (mmps), including mmp9 and mmp13a. We also identified naringin as one of the constituents of GSB responsible for the herbal extract's anti-GIOP activity. CONCLUSIONS: Using the in vivo zebrafish GIOP model that we established, the efficacy of traditional Chinese medicines in treating GIOP could be systematically investigated. GSB has an osteogenic effect and may thus be an efficacious and cost-effective treatment option for GIOP. Notably, bone resorption activity was found to be retained after GSB treatment, which would be beneficial for maintaining normal bone remodeling.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Peng CH, Lin WY, Li CY, et al. Gu Sui Bu (Drynaria fortunei J. Sm.) antagonizes glucocorticoid-induced mineralization reduction in zebrafish larvae by modulating the activity of osteoblasts and osteoclasts. J Ethnopharmacol. 2022. PMID: 35863613. doi:10.1016/j.jep.2022.115565

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。